Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_assertion type Assertion NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_head.
- NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_assertion description "[Consistent with this, relatively lower levels of AGR2 were highly predictive of disease recurrence in patients who had originally presented with high-stage primary prostate cancer (P = 0.009).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_provenance.
- NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_assertion evidence source_evidence_literature NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_provenance.
- NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_assertion SIO_000772 21144054 NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_provenance.
- NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_assertion wasDerivedFrom befree-20140225 NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_provenance.
- NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_assertion wasGeneratedBy ECO_0000203 NP800017.RAq3dRJ8WMDIAIqMyTEt1RQVdG0ETOz0s4ribwJvLXKeE130_provenance.